Under construction – not a live service
Sign in
Taking people in IndiaNo phase

Comparing bowel ultrasound with colonoscopy for ulcerative colitis and Crohn's disease

Studies bowel ultrasound against colonoscopy and scans in adults with bowel inflammation.

Plain-language title generated from the registry record
Registry title: Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

Key facts

Where
Hyderabad, IndiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07431983, who can take part

Where in India

  • AIG HospitalsHyderabad, IndiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Asian Institute of Gastroenterology, India
Trial code
NCT07431983
Record updated
12 May 2026
Original description
Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.Read full original descriptionShow less

Prospective Evaluation of the Carbon Footprint and Clinical Utility of Intestinal Bowel Ultrasound Compared to Colonoscopy and Enterography in Ulcerative Colitis and Crohn's Disease

Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.

All consecutive patients undergoing endoscopy procedures with consent for procedures, during the study period will be included.

ClinicalTrials.gov NCT07431983